Capricor Therapeutics (CAPR) EBT Margin Growth (5y) (2016 - 2024)
Capricor Therapeutics (CAPR) EBT Margin Growth (5y) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Capricor Therapeutics | 457.86 Mn | 457.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 59,659.00 |
| Sep 30, 2024 | -458,397.00 |
| Jun 30, 2024 | -7,920.00 |
| Mar 31, 2024 | 89,581.00 |
| Dec 31, 2023 | 49,172.00 |
| Sep 30, 2023 | 171,476.00 |
| Jun 30, 2023 | 53,386.00 |
| Mar 31, 2023 | 71,875.00 |
| Dec 31, 2022 | -8,009.00 |
| Sep 30, 2022 | -64,998.00 |
| Jun 30, 2021 | -33,577.00 |
| Mar 31, 2021 | -1.23 Mn |
| Dec 31, 2020 | -709,560.00 |
| Sep 30, 2020 | -7.04 Mn |
| Jun 30, 2020 | -2.09 Mn |
| Mar 31, 2020 | -97,415.00 |
| Dec 31, 2019 | -61,746.00 |
| Sep 30, 2019 | -106,264.00 |
| Jun 30, 2019 | -35,622.00 |
| Dec 31, 2017 | -68,868.00 |